TITAN PHARMACEUTICAL (TTP) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : TITAN PHARMACEUTICAL (TTP)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Icebrg who wrote (233)	10/17/2002 8:59:44 AM
From: Icebrg	Read Replies (2) of 362

Novartis might not have shelved Iloperidone yet after all. Novartis open to Prexige partner, not stopped Zomaril Thursday October 17, 8:49 am ET ZURICH, Oct 17 (Reuters) - Swiss healthcare firm Novartis AG (NOVZn.VX) is still open to the idea of finding a marketing partner for its Prexige pain killing drug and will likely decide on this next year, officials at Europe's third-largest drugs group said on a conference call on Thursday. Officials said Novartis had not stopped development of its Zomaril drug for schizophrenia along with Titan Pharmaceuticals Inc (AMEX:TTP - News), and also said Novartis would start to report in U.S. dollars from the first quarter of next year.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next